Fenway Health
Boston, Massachusetts 02215-4302
3 studies enrolling now · 21 studies all time
What they study most
Adherence, Medication, Adherence, Treatment, Alcohol Drinking, Anal Cancer, Antiretroviral Therapy, Anxiety, Depression, Gender Minority Stress, Genital Herpes, HIV, HIV Infection, HIV Infections
Studies at this site
- Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention — Recruiting now
- Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders — Recruiting now
- Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs — Recruiting now
- A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV — Running, not enrolling
- SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder — Completed
- Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) — Running, not enrolling
- A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes — Completed
- Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) — Running, not enrolling
- Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care — Completed
- Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV — Stopped early
- Project QUIT+: Adapting and Testing a Smoking Cessation Intervention for Transgender and Gender Expansive Individuals — Stopped early
- A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults — Completed
- Next Generation Ingestible Sensors for Medication Adherence Measurement — Completed
- Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care — Completed
- A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals — Completed
- Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions — Completed
- Life Steps for PrEP for Youth — Completed
- PCORnet Opioid Surveillance Study — Completed
- Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting — Completed
- HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse — Completed
- Addressing Discrimination and Mistrust Among Black Men: Phase III — Completed